Position in GILD
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$5,977,398
-$771,872 QoQ
Shares Held
47,312
-2.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
#535
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cypress Capital Group holds $135,758,423 across 9 Drug Manufacturers - General names. GILD ranks #6 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
47,680 | $57,188,826 | |
| 2 | ABBV |
AbbVie Inc.
|
111,026 | $27,938,581 | |
| 3 | JNJ |
Johnson & Johnson
|
82,604 | $20,978,936 | |
| 4 | MRK |
Merck & Co., Inc.
|
62,260 | $8,000,410 | |
| 5 | AMGN |
Amgen Inc
|
18,021 | $6,525,764 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
47,312 | $5,977,398 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
84,745 | $4,883,006 | |
| 8 | PFE |
Pfizer Inc
|
138,473 | $3,334,429 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,977,398 | 47,312 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $6,749,270 | 48,427 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,963,445 | 48,586 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $5,395,044 | 48,604 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $5,380,853 | 48,533 | Shares | Defined | 2025-07-25 | |
| 2025-03-31 | $5,376,383 | 47,982 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $4,536,382 | 49,111 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $4,215,810 | 50,284 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $3,493,552 | 50,919 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $3,736,335 | 51,008 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $4,164,481 | 51,407 | Shares | Defined | 2024-01-24 | |
| 2023-09-30 | $4,215,898 | 56,257 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $4,474,606 | 58,059 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $5,096,846 | 61,430 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $6,325,943 | 73,686 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,551,179 | 73,775 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $4,499,334 | 72,793 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $3,884,937 | 65,348 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,838,454 | 52,864 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $3,027,087 | 43,337 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $3,050,565 | 44,301 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $2,883,400 | 44,614 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $2,543,805 | 43,663 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $2,890,245 | 45,739 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $4,258,012 | 55,342 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $3,557,303 | 47,583 | Shares | Sole | 2020-04-08 | |
| No filing history on record for this holder in this stock. | ||||||